azacitidine has been researched along with Kidney Failure in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Douvali, E; Kotsianidis, I; Papadopoulos, V; Papoutselis, M; Spanoudakis, E; Tsatalas, C; Vassilakopoulos, TP | 1 |
| Beach, CL; Gabrail, NY; Goel, S; Kelly, K; Laille, E; Liu, L; Mita, AC; Songer, S | 1 |
| Batty, GN; Cortés, JE; Garcia-Manero, G; Issa, JP; Jabbour, E; Kantarjian, H; McCue, D; O'Brien, S; Pierce, S; Ravandi, F; Santos, FP | 1 |
| Dalal, J; Gonzalez, C; Kearns, GL; Peters, C; Tsao, CF | 1 |
1 trial(s) available for azacitidine and Kidney Failure
| Article | Year |
|---|---|
A phase I study in patients with solid or hematologic malignancies of the dose proportionality of subcutaneous Azacitidine and its pharmacokinetics in patients with severe renal impairment.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Renal Insufficiency; Severity of Illness Index; Time Factors | 2014 |
3 other study(ies) available for azacitidine and Kidney Failure
| Article | Year |
|---|---|
Safety and efficacy of 5-azacytidine treatment in myelodysplastic syndrome patients with moderate and mild renal impairment.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Disease-Free Survival; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Infections; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Remission Induction; Renal Insufficiency; Retrospective Studies; Thrombocytopenia; Treatment Outcome | 2013 |
Feasibility of therapy with hypomethylating agents in patients with renal insufficiency.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Humans; Kaplan-Meier Estimate; Kidney; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Middle Aged; Myelodysplastic Syndromes; Renal Insufficiency | 2010 |
Azacitidine pharmacokinetics in an adolescent patient with renal compromise.
Topics: Acute Disease; Adolescent; Azacitidine; Chimerism; Dose-Response Relationship, Drug; Drug Administration Schedule; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Injections, Subcutaneous; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Recurrence; Renal Insufficiency; Treatment Outcome | 2007 |